Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Classement en actions #40869
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Prix de l'action
$0.02765
Dernière synchronisation: 2024-12-23
Capitalisation boursière
$69.04K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Histogen Inc. (HSTO)

Catégorie

Historique du prix de l'action pour Histogen Inc. (HSTO)
Prix de clôture le plus élevé : $0.02 le 2024-12-01

Prix de clôture le plus bas : $186.88 le 2013-07-01
Historique du prix de l'action de Histogen Inc. de 2013 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 -28.82%
2023 -66.41%
2022 -88.05%
2021 -66.17%
2020 -68.37%
2019 -78.98%
2018 -59.92%
2017 45.54%
2016 4.61%
2015 -61.12%
2014 15.35%
2013 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$518.32 30.92%
US
$862.10 33.33%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE